A Post Marketing Surveillance Study of Equfina Tablet 50 Milligram (mg)
NCT05225324
·
clinicaltrials.gov ↗
COMPLETED
Status
702
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Equfina 50 mg
Sponsor
Eisai Korea Inc.